Trial intelligence / Profile preview

Clinical evaluation and treatment of voice tremor with botulinum toxin and propranolol

RBR-389mznPhase 4Recruiting

Sponsor
Federal University of São Paulo
Start
Apr 2011
Modality
Small Molecules, Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 4, open-label trial of propranolol and botulinum toxin type A in Essential vocal tremor (EVT) (2 arms), sponsored by Federal University of São Paulo. Started Apr 2011; status: recruiting.

02

Drugs

propranololbotulinum toxin type A
03

Conditions

Essential vocal tremor (EVT)

Beyond the preview

Go deeper on RBR-389mzn.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on RBR-389mzn.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call